Sanofi Consumer Healthcare India has been listed on the BSE and NSE following its demerger from Sanofi India. The listing marks a significant milestone for the company, as it aims to capitalize on India's growing consumer healthcare market.
New Delhi, Sep 13 (PTI) Sanofi Consumer Healthcare India on Friday said it has been listed on the BSE and the National Stock Exchange.
Sanofi Consumer Healthcare India has emerged as a distinct legal entity following its demerger from Sanofi India.
The demerger, executed under the Scheme of Arrangement, was sanctioned by the Mumbai bench of the National Company Law Tribunal and became effective on June 1, 2024.
"India's consumer healthcare market, has vast potential. SCHIL getting listed on the BSE and NSE, marks a critical milestone for us; one that is further expected to strengthen our position and drive sustainable growth within the Indian market," Sanofi Consumer Healthcare India MD Himanshu Bakshi said in a statement.
By evaluating business needs, capitalising on emerging consumer trends in the healthcare space and encouraging a culture of digital innovations, the company seeks to address unmet consumer needs, he added.
Home » Market News » Sanofi Consumer Healthcare Listed on BSE, NSE
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback